Advertisement

You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

March 7, 2014

Web Version  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

Careless antibiotic prescribing hurts patients

Poor antibiotic prescribing practices are putting patients at risk for allergic reactions, super-resistant infections, and deadly diarrhea cause by Clostridium difficile, according to new report from the Centers for Disease Control and Prevention. » Full article

FDA: In case you missed it

A thrice-rejected testosterone drug is among FDA’s newest approvals. » Full article

Continuing Education

New CPE series: MTM Considerations for Adult Patients with CVD

Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

VIDEO: NIH study seeks best way to safely step down asthma therapy

Researchers at The Ohio State University Wexner Medical Center are 1 of 18 clinical research centers taking part in a national study to establish guidelines for safely stepping down treatment in patients whose asthma is well controlled. » Full article

 

Related Articles

Azithromycin falls out of favor for common infections

FDA drug approvals: March 2014

RESOURCES

Drug Watch

Latest Clinical News

 
Powered by Modern Medicine Advanstar Medical Communications Group